How much funding has GeneFluidics, Inc. raised?

GeneFluidics, Inc. has raised $244K in total funding, most recently a Grant round.

Who are GeneFluidics, Inc.'s investors?

GeneFluidics, Inc.'s investors include HHS NIH SBIR Phase II.

When was GeneFluidics, Inc. founded?

GeneFluidics, Inc. was founded in 2015.

Where is GeneFluidics, Inc. headquartered?

GeneFluidics, Inc. is headquartered in Irwindale, California, United States.

What industry is GeneFluidics, Inc. in?

GeneFluidics, Inc. operates in Biotech, Healthcare.

GeneFluidics, Inc.

Rapid diagnostic testing through bionano and microfluidic technology

Irwindale, United States · Founded 2015 · $244K raised

Biotech

Healthcare

Headquarters: Irwindale, California
Founded: 2015
Business Model: B2B
Website: genefluidics.com

Total Funding: $244K
Last Round: $244K GrantJan 2009
Rounds: 1

About

GeneFluidics was incorporated in 2000 to develop fast, accurate, and simple testing systems for improving worldwide healthcare. The company integrates novel bionano and microfluidic technologies to enable complex diagnostic tests — normally requiring skilled laboratory technicians — to be performed by anyone, anywhere. Its platform supports electrochemical detection, robotic systems, immunoassays, and genetic assays.

Summary

GeneFluidics, Inc. is a Biotech company based in Irwindale, United States, founded in 2015. It has raised $244K in total across 1 round, most recently a $244K Grant round in Jan 2009. Investors include HHS NIH SBIR Phase II.